News
The Cigna Group Foundation today announced the ... monthly out-of-pocket expenses for weight-loss drugs Zepbound and Wegovy to $200. Beginning in the second half of 2025, the program targets ...
May 22, 2025 Cigna to offer $200 Wegovy, Zepbound weight-loss benefit Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Bloomfield-headquartered health insurer and pharmacy-benefit manager The Cigna Group ... on lowering patients’ expenditures for the Wegovy and Zepbound weight-loss medications.
Cigna to offer $200 Wegovy, Zepbound weight-loss benefit Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an add-on to its ...
Fifteen Connecticut companies made the 2025 Fortune 500 list of the largest U.S. corporations, which was announced Monday-- a sign of stability in the state's corporate sector. Bloomfield- ...
Some Blue Cross and Blue Shield insurers dipped their toes into expanding coverage for blockbuster weight-loss drugs, then ...
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
Meanwhile, the Danish drugmaker was also bolstered by the decision by pharmacy benefit manager (PBM) CVS Health to remove Zepbound but retain Wegovy on its formulary of reimbursed medicines.
The results of the first head-to-head trial of Lilly's dual GLP-1/GIP agonist Zepbound (tirzepatide) and Novo Nordisk's GLP-1 agonist Wegovy (semaglutide) have shown experimentally what has been ...
While employers aren’t yet reimbursing weight loss drugs en masse, significantly reduced net costs could affect their future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results